BRCA1/2
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes (NCT03396341) | Memorial Sloan Kettering Cancer Center | 2018-01-04 |
Track BRCA1/2 automatically
Every clearance here is in the API, with alerts when new ones post.